Scholar Rock Holding SRRK
NASDAQ SRRK
$47.09 +0.93 (+2.01%)
As of: Oct 2, 2026 · 10:10 AM EDT

Scholar Rock Holding (SRRK) Liabilities and Shareholders Equity (2017 - 2026)

Updated

Scholar Rock Holding (SRRK) posted Liabilities and Shareholders Equity of $523.54 million for Q2 2026, up 54.0% from $340.05 million a year earlier but down 2.2% from the prior quarter.

Analysis

Scholar Rock Holding (SRRK) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends

At the end of FY2025, Scholar Rock Holding's Liabilities and Shareholders Equity came in at $404.27 million, down 14.9% from FY2024.

  • Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of 0.8% (FY2020 to FY2025).
  • In prior years, Scholar Rock Holding's Liabilities and Shareholders Equity was $474.92 million in FY2024 (+52.7%), $311.04 million in FY2023 (-13.2%), $358.17 million in FY2022 (+17.6%) and $304.45 million in FY2021 (-21.6%).
  • Quarterly Liabilities and Shareholders Equity has run from a low of $179.13 million in Q3 2024 to a high of $535.25 million in Q1 2026 over five years.
  • On a year-over-year basis, Liabilities and Shareholders Equity increased in six of the last eight quarters, with growth averaging 40.8%.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q3 2025, with growth of 129.8%; the weakest was Q3 2023, with a decline of 35.8%.
  • According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $535.25 million (Q1 2026), $404.27 million (Q4 2025) and $411.72 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Scholar Rock Holding 5.88 Bn 5.88 Bn - 523.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 523.54 Mn
Mar 31, 2026 535.25 Mn
Dec 31, 2025 404.27 Mn
Sep 30, 2025 411.72 Mn
Jun 30, 2025 340.05 Mn
Mar 31, 2025 407.55 Mn
Dec 31, 2024 474.92 Mn
Sep 30, 2024 179.13 Mn
Jun 30, 2024 226.87 Mn
Mar 31, 2024 267.29 Mn
Dec 31, 2023 311.04 Mn
Sep 30, 2023 250.69 Mn
Jun 30, 2023 284.90 Mn
Mar 31, 2023 314.72 Mn
Dec 31, 2022 358.17 Mn
Sep 30, 2022 390.30 Mn
Jun 30, 2022 424.13 Mn
Mar 31, 2022 265.98 Mn
Dec 31, 2021 304.45 Mn
Sep 30, 2021 298.39 Mn
API Access

Scholar Rock Holding Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SRRK&period=max&api_key=YOUR_API_KEY